TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Interplay of Social, Normative, and Legal Marijuana Environments and Marijuana and ATOD Use From Late Childhood to Young Adulthood
Brief Summary: The Community Youth Development Study is an experimental test of the Communities That Care (CTC) prevention planning system. It has been designed to find out if communities that were trained to use the CTC system improved public health by reducing rates of adolescent drug use, delinquency, violence, and risky sexual behavior when compared to communities that did not use this approach. The primary purpose of the current continuation study is to investigate whether CTC has long-term effects on substance use, antisocial behavior, and violence, as well as secondary effects on educational attainment, mental health, and sexual risk behavior in young adults at ages 26 and 28. The continuation study also examines (a) how the interaction of social, normative, and legal marijuana contexts creates variation in the permissiveness of individuals' marijuana environments from late childhood to young adulthood and (b) whether, when, and for whom permissive marijuana environments increase marijuana and ATOD use and misuse from age 11 to 28 and interfere with the adoption of adult roles.


Options:
A: Arm Label: Mother Program; Type: EXPERIMENTAL; Interventions: Behavioral: New Beginnings Program | Arm Label: Mother Plus Child Program; Type: EXPERIMENTAL; Interventions: Behavioral: New Beginnings Program | Arm Label: Literature Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: New Beginnings Program; Assigned to Arm(s): Mother Plus Child Program, Mother Program
B: Arm Label: Örebro prevention program; Type: EXPERIMENTAL; Interventions: Behavioral: Örebro prevention program | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Business as usual | Intervention Type: BEHAVIORAL; Name: Örebro prevention program; Assigned to Arm(s): Örebro prevention program | Intervention Type: BEHAVIORAL; Name: Business as usual; Assigned to Arm(s): Control
C: Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Communities That Care Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communities That Care | Intervention Type: BEHAVIORAL; Name: Communities That Care; Assigned to Arm(s): Communities That Care Intervention
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: brief intervention (cognitive-behavioral therapy) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: brief intervention (cognitive-behavioral therapy) | Intervention Type: BEHAVIORAL; Name: brief intervention (cognitive-behavioral therapy); Assigned to Arm(s): 1, 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Interplay of Social, Normative, and Legal Marijuana Environments and Marijuana and ATOD Use From Late Childhood to Young Adulthood
Brief Summary: The Community Youth Development Study is an experimental test of the Communities That Care (CTC) prevention planning system. It has been designed to find out if communities that were trained to use the CTC system improved public health by reducing rates of adolescent drug use, delinquency, violence, and risky sexual behavior when compared to communities that did not use this approach. The primary purpose of the current continuation study is to investigate whether CTC has long-term effects on substance use, antisocial behavior, and violence, as well as secondary effects on educational attainment, mental health, and sexual risk behavior in young adults at ages 26 and 28. The continuation study also examines (a) how the interaction of social, normative, and legal marijuana contexts creates variation in the permissiveness of individuals' marijuana environments from late childhood to young adulthood and (b) whether, when, and for whom permissive marijuana environments increase marijuana and ATOD use and misuse from age 11 to 28 and interfere with the adoption of adult roles.


Options:
A: Arm Label: Fruit and Vegetable Intake Behavioral Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Fruit and vegetable intake in rural youth | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Fruit and vegetable intake in rural youth; Assigned to Arm(s): Fruit and Vegetable Intake Behavioral Intervention
B: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: home visitation | Intervention Type: BEHAVIORAL; Name: home visitation; Assigned to Arm(s): 2
C: Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Communities That Care Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communities That Care | Intervention Type: BEHAVIORAL; Name: Communities That Care; Assigned to Arm(s): Communities That Care Intervention
D: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Home visitation through pregnancy; Type: EXPERIMENTAL; Interventions: Behavioral: nurse home visitation | Arm Label: Home visitation through age 2; Type: EXPERIMENTAL; Interventions: Behavioral: nurse home visitation | Intervention Type: BEHAVIORAL; Name: nurse home visitation; Assigned to Arm(s): Home visitation through age 2, Home visitation through pregnancy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Interplay of Social, Normative, and Legal Marijuana Environments and Marijuana and ATOD Use From Late Childhood to Young Adulthood
Brief Summary: The Community Youth Development Study is an experimental test of the Communities That Care (CTC) prevention planning system. It has been designed to find out if communities that were trained to use the CTC system improved public health by reducing rates of adolescent drug use, delinquency, violence, and risky sexual behavior when compared to communities that did not use this approach. The primary purpose of the current continuation study is to investigate whether CTC has long-term effects on substance use, antisocial behavior, and violence, as well as secondary effects on educational attainment, mental health, and sexual risk behavior in young adults at ages 26 and 28. The continuation study also examines (a) how the interaction of social, normative, and legal marijuana contexts creates variation in the permissiveness of individuals' marijuana environments from late childhood to young adulthood and (b) whether, when, and for whom permissive marijuana environments increase marijuana and ATOD use and misuse from age 11 to 28 and interfere with the adoption of adult roles.


Options:
A: Intervention Type: BEHAVIORAL; Name: lifestyle intervention; Assigned to Arm(s): N/A
B: Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Communities That Care Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communities That Care | Intervention Type: BEHAVIORAL; Name: Communities That Care; Assigned to Arm(s): Communities That Care Intervention
C: Arm Label: Peer-Led Stroke Recurrence Prevention Education; Type: EXPERIMENTAL; Interventions: Behavioral: Prevent Return of Stroke | Arm Label: Usual Care (Delayed Intervention); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Prevent Return of Stroke | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Peer-Led Stroke Recurrence Prevention Education | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Usual Care (Delayed Intervention)
D: Arm Label: Passive Arm #1; Type: EXPERIMENTAL; Interventions: Behavioral: Active Arm #1, #2, Passive Arm #1, #2 | Arm Label: Passive Arm #2; Type: EXPERIMENTAL; Interventions: Behavioral: Active Arm #1, #2, Passive Arm #1, #2 | Arm Label: Active Arm #1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Arm #1, #2, Passive Arm #1, #2 | Arm Label: Active Arm #2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Arm #1, #2, Passive Arm #1, #2 | Intervention Type: BEHAVIORAL; Name: Active Arm #1, #2, Passive Arm #1, #2; Assigned to Arm(s): Active Arm #1, Active Arm #2, Passive Arm #1, Passive Arm #2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Acute Effect of Continuous Positive Airway Pressure on Left Ventricular Diastolic Function and Exercise Tolerance in Compensated Heart Failure
Brief Summary: Acute effects of CPAP on diastolic function in patients with compensated heart failure (CHF) are unknown. The investigators hypothesized that acutely CPAP improves diastolic function, which is associated with increases exercise tolerance.

Objective: To evaluate the acute effects of CPAP on functional capacity and diastolic indices of patients with CHF. This is a randomized trial including 44 patients with compensated heart failure (functional classes II or III, NYHA). Patients will be allocated in CPAP(CPAP with 10cmH2O) or simulated CPAP (null pressure) after computed randomization, in a 1:1 ratio. All subjects shall complete a 6-minute walk test (6MWT) before and after CPAP (30 minutes; 10 cm H2O pressure). Doppler-echocardiogram will be performed before and at the end of CPAP. Wilcoxon or paired t tests were used to compare results, with significance level at p \< 0.05.


Options:
A: Arm Label: MV ASV+OMT; Type: EXPERIMENTAL; Interventions: Device: MV ASV, Drug: Optimized Medical Treatment | Arm Label: OMT only; Type: ACTIVE_COMPARATOR; Interventions: Drug: Optimized Medical Treatment | Intervention Type: DEVICE; Name: MV ASV; Assigned to Arm(s): MV ASV+OMT | Intervention Type: DRUG; Name: Optimized Medical Treatment; Assigned to Arm(s): MV ASV+OMT, OMT only
B: Arm Label: Nocturnal oxygen therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Nocturnal oxygen | Arm Label: Adaptive servo ventilation; Type: ACTIVE_COMPARATOR; Interventions: Device: Adaptive servo ventilation | Intervention Type: DEVICE; Name: Adaptive servo ventilation; Assigned to Arm(s): Adaptive servo ventilation | Intervention Type: DEVICE; Name: Nocturnal oxygen; Assigned to Arm(s): Nocturnal oxygen therapy
C: Arm Label: Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Europe: AutoSet CS (USA: VPAP Adapt SV) | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Europe: AutoSet CS (USA: VPAP Adapt SV); Assigned to Arm(s): Treatment Group
D: Arm Label: positive airway pressure; Type: EXPERIMENTAL; Interventions: Device: CPAP | Intervention Type: DEVICE; Name: CPAP; Assigned to Arm(s): positive airway pressure

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open-label, Exploratory Study to Establish the Safety and Efficacy of 3 Months Treatment With Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever
Brief Summary: Establish the safety and efficacy of 3 months treatment with canakinumab in patients with colchicine resistant Familial Mediterranean Fever.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Rilonacept | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Rilonacept; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Arm Label: once daily dosage schema of colchicine; Type: EXPERIMENTAL; Interventions: Drug: colchicine | Arm Label: twice daily dosage schema of colchicine; Type: EXPERIMENTAL; Interventions: Drug: colchicine | Intervention Type: DRUG; Name: colchicine; Assigned to Arm(s): once daily dosage schema of colchicine, twice daily dosage schema of colchicine
C: Arm Label: Canakinumab; Type: EXPERIMENTAL; Interventions: Drug: Canakinumab | Intervention Type: DRUG; Name: Canakinumab; Assigned to Arm(s): Canakinumab
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: rilonacept 160 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: rilonacept 160 mg | Arm Label: Open-Label rilonacept 160 mg; Type: OTHER; Interventions: Drug: rilonacept 160 mg | Intervention Type: DRUG; Name: rilonacept 160 mg; Assigned to Arm(s): rilonacept 160 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: rilonacept 160 mg; Assigned to Arm(s): Open-Label rilonacept 160 mg

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open-label, Exploratory Study to Establish the Safety and Efficacy of 3 Months Treatment With Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever
Brief Summary: Establish the safety and efficacy of 3 months treatment with canakinumab in patients with colchicine resistant Familial Mediterranean Fever.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Rilonacept | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Rilonacept; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Arm Label: Vehicle; Type: PLACEBO_COMPARATOR; Interventions: Drug: Kineret | Arm Label: Kineret (Anakinra); Type: EXPERIMENTAL; Interventions: Drug: Kineret | Intervention Type: DRUG; Name: Kineret; Assigned to Arm(s): Kineret (Anakinra), Vehicle
C: Arm Label: Canakinumab; Type: EXPERIMENTAL; Interventions: Drug: Canakinumab | Intervention Type: DRUG; Name: Canakinumab; Assigned to Arm(s): Canakinumab
D: Arm Label: Placebo (for Rilonacept) and Indomethacin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Indomethacin, Other: Placebo (for Rilonacept) | Arm Label: Rilonacept and Indomethacin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Rilonacept, Drug: Indomethacin | Arm Label: Rilonacept and Placebo (for Indomethacin); Type: ACTIVE_COMPARATOR; Interventions: Drug: Rilonacept, Other: Placebo (for Indomethacin) | Intervention Type: DRUG; Name: Rilonacept; Assigned to Arm(s): Rilonacept and Indomethacin, Rilonacept and Placebo (for Indomethacin) | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): Placebo (for Rilonacept) and Indomethacin, Rilonacept and Indomethacin | Intervention Type: OTHER; Name: Placebo (for Indomethacin); Assigned to Arm(s): Rilonacept and Placebo (for Indomethacin) | Intervention Type: OTHER; Name: Placebo (for Rilonacept); Assigned to Arm(s): Placebo (for Rilonacept) and Indomethacin

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Diarrhea, Malaria, Anemia, and Helminthiasis Prevention Through Household-based Interventions in Rural Western Kenya: the Nyando Integrated Child Health and Education (NICHE) Project
Brief Summary: The purpose of the study is to evaluate the effectiveness of household-based distribution of evidence-based health products and to measure the health impact of these combined interventions on a population basis.


Options:
A: Arm Label: Micronutrient Sprinkles; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Micronutrient powders (Sprinkles) | Intervention Type: DIETARY_SUPPLEMENT; Name: Micronutrient powders (Sprinkles); Assigned to Arm(s): Micronutrient Sprinkles
B: Arm Label: Programme; Type: EXPERIMENTAL; Interventions: Other: MNP + IYCN counseling + cooking demonstrations | Arm Label: Controle; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: MNP + IYCN counseling + cooking demonstrations; Assigned to Arm(s): Programme
C: Arm Label: Iron and Folic Acid (IFA)/Micronutrient Powders (MNP); Type: EXPERIMENTAL; Interventions: Dietary Supplement: Iron and Folic Acid (IFA), Dietary Supplement: Micronutrient Powders (MNP), Behavioral: Iron Plus Strategy Counseling | Arm Label: Micronutrient Powders (MNP)/Iron and Folic Acid (IFA); Type: EXPERIMENTAL; Interventions: Dietary Supplement: Iron and Folic Acid (IFA), Dietary Supplement: Micronutrient Powders (MNP), Behavioral: Iron Plus Strategy Counseling | Intervention Type: DIETARY_SUPPLEMENT; Name: Iron and Folic Acid (IFA); Assigned to Arm(s): Iron and Folic Acid (IFA)/Micronutrient Powders (MNP), Micronutrient Powders (MNP)/Iron and Folic Acid (IFA) | Intervention Type: DIETARY_SUPPLEMENT; Name: Micronutrient Powders (MNP); Assigned to Arm(s): Iron and Folic Acid (IFA)/Micronutrient Powders (MNP), Micronutrient Powders (MNP)/Iron and Folic Acid (IFA) | Intervention Type: BEHAVIORAL; Name: Iron Plus Strategy Counseling; Assigned to Arm(s): Iron and Folic Acid (IFA)/Micronutrient Powders (MNP), Micronutrient Powders (MNP)/Iron and Folic Acid (IFA)
D: Arm Label: Vitamin/mineral fortificant with iron; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Sprinkles® | Arm Label: Vitamin/mineral fortificant without iron; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: vitamin/mineral fortificant without iron | Intervention Type: DIETARY_SUPPLEMENT; Name: Sprinkles®; Assigned to Arm(s): Vitamin/mineral fortificant with iron | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin/mineral fortificant without iron; Assigned to Arm(s): Vitamin/mineral fortificant without iron

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Diarrhea, Malaria, Anemia, and Helminthiasis Prevention Through Household-based Interventions in Rural Western Kenya: the Nyando Integrated Child Health and Education (NICHE) Project
Brief Summary: The purpose of the study is to evaluate the effectiveness of household-based distribution of evidence-based health products and to measure the health impact of these combined interventions on a population basis.


Options:
A: Arm Label: Vitamin/mineral fortificant with iron; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Sprinkles® | Arm Label: Vitamin/mineral fortificant without iron; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: vitamin/mineral fortificant without iron | Intervention Type: DIETARY_SUPPLEMENT; Name: Sprinkles®; Assigned to Arm(s): Vitamin/mineral fortificant with iron | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin/mineral fortificant without iron; Assigned to Arm(s): Vitamin/mineral fortificant without iron
B: Arm Label: Essential Health Care (EHC) only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mass media | Arm Label: EHC + Micronutrient Powders; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Micronutrient powders, Behavioral: Mass media | Arm Label: EHC + BCC; Type: EXPERIMENTAL; Interventions: Behavioral: EHC + BCC, Behavioral: Mass media | Arm Label: EHC + BCC + Micronutrient powders; Type: EXPERIMENTAL; Interventions: Behavioral: EHC + BCC, Dietary Supplement: Micronutrient powders, Behavioral: Mass media | Intervention Type: BEHAVIORAL; Name: EHC + BCC; Assigned to Arm(s): EHC + BCC, EHC + BCC + Micronutrient powders | Intervention Type: DIETARY_SUPPLEMENT; Name: Micronutrient powders; Assigned to Arm(s): EHC + BCC + Micronutrient powders, EHC + Micronutrient Powders | Intervention Type: BEHAVIORAL; Name: Mass media; Assigned to Arm(s): EHC + BCC, EHC + BCC + Micronutrient powders, EHC + Micronutrient Powders, Essential Health Care (EHC) only
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Other: Nutritional Counselling and Education | Arm Label: B; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Micronutrient Supplementation without Zinc | Arm Label: C; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Micronutrient Supplementation with Zinc | Intervention Type: DIETARY_SUPPLEMENT; Name: Micronutrient Supplementation without Zinc; Assigned to Arm(s): B | Intervention Type: DIETARY_SUPPLEMENT; Name: Micronutrient Supplementation with Zinc; Assigned to Arm(s): C | Intervention Type: OTHER; Name: Nutritional Counselling and Education; Assigned to Arm(s): A
D: Arm Label: Micronutrient Sprinkles; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Micronutrient powders (Sprinkles) | Intervention Type: DIETARY_SUPPLEMENT; Name: Micronutrient powders (Sprinkles); Assigned to Arm(s): Micronutrient Sprinkles

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Diarrhea, Malaria, Anemia, and Helminthiasis Prevention Through Household-based Interventions in Rural Western Kenya: the Nyando Integrated Child Health and Education (NICHE) Project
Brief Summary: The purpose of the study is to evaluate the effectiveness of household-based distribution of evidence-based health products and to measure the health impact of these combined interventions on a population basis.


Options:
A: Arm Label: Zalewa; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Household model | Arm Label: Ligowe and Magaleta; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Household model | Arm Label: Neno District Hospital and Neno Parish; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Household model | Arm Label: Matope; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Household model | Arm Label: Matandani and Nsambe; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Household model | Arm Label: Luwani, Nkula, and Midzemba; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Household model | Intervention Type: BEHAVIORAL; Name: Household model; Assigned to Arm(s): Ligowe and Magaleta, Luwani, Nkula, and Midzemba, Matandani and Nsambe, Matope, Neno District Hospital and Neno Parish, Zalewa
B: Arm Label: Screening by community health workers; Type: ACTIVE_COMPARATOR; Interventions: Other: Active comparator: Screening by community health workers | Arm Label: Screening by mothers; Type: EXPERIMENTAL; Interventions: Other: Screening by mothers | Intervention Type: OTHER; Name: Screening by mothers; Assigned to Arm(s): Screening by mothers | Intervention Type: OTHER; Name: Active comparator: Screening by community health workers; Assigned to Arm(s): Screening by community health workers
C: Arm Label: Micronutrient Sprinkles; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Micronutrient powders (Sprinkles) | Intervention Type: DIETARY_SUPPLEMENT; Name: Micronutrient powders (Sprinkles); Assigned to Arm(s): Micronutrient Sprinkles
D: Arm Label: Current protocol; Type: ACTIVE_COMPARATOR; Interventions: Other: Current protocol | Arm Label: Integrated Protocol; Type: EXPERIMENTAL; Interventions: Other: Integrated Protocol | Intervention Type: OTHER; Name: Integrated Protocol; Assigned to Arm(s): Integrated Protocol | Intervention Type: OTHER; Name: Current protocol; Assigned to Arm(s): Current protocol

Answer: C